• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Recent Advances in the Application of 2-Bromo-4-iodophenol (CAS: 133430-98-5) in Chemical Biology and Pharmaceutical Research

2-Bromo-4-iodophenol (CAS: 133430-98-5) is a halogenated phenolic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial intermediate in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and materials. Its unique structural features, characterized by the presence of both bromine and iodine substituents, make it a valuable building block for cross-coupling reactions and other synthetic transformations. Recent studies have explored its potential in drug discovery, particularly in the development of kinase inhibitors and antimicrobial agents.

One of the most notable advancements in the use of 2-Bromo-4-iodophenol is its role in the synthesis of novel kinase inhibitors. Kinases are key regulators of cellular signaling pathways and are often implicated in diseases such as cancer and inflammatory disorders. Researchers have leveraged the reactivity of 2-Bromo-4-iodophenol to construct complex heterocyclic scaffolds that exhibit potent inhibitory activity against specific kinase targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of this compound in the synthesis of a new class of BTK (Bruton's tyrosine kinase) inhibitors, which show promise for treating B-cell malignancies.

In addition to its applications in drug discovery, 2-Bromo-4-iodophenol has also been employed in the development of antimicrobial agents. The halogen atoms in this compound contribute to its ability to disrupt microbial cell membranes and inhibit essential enzymatic processes. A recent study in Bioorganic & Medicinal Chemistry Letters highlighted the synthesis of a series of halogenated phenolic derivatives, including 2-Bromo-4-iodophenol, which exhibited broad-spectrum activity against drug-resistant bacterial strains. These findings underscore the potential of this compound in addressing the growing challenge of antibiotic resistance.

Beyond its biological applications, 2-Bromo-4-iodophenol has also found use in materials science. Its ability to participate in Suzuki-Miyaura and other cross-coupling reactions makes it a valuable precursor for the synthesis of conjugated polymers and organic electronic materials. Researchers have reported the use of this compound in the fabrication of organic light-emitting diodes (OLEDs) and photovoltaic devices, where its halogenated structure enhances charge transport properties. A 2022 study in Advanced Materials detailed the incorporation of 2-Bromo-4-iodophenol into a novel polymer backbone, resulting in improved device performance and stability.

Despite its promising applications, the handling and use of 2-Bromo-4-iodophenol require careful consideration of safety and environmental concerns. The compound's halogenated nature poses potential toxicity risks, and proper disposal methods must be followed to minimize environmental impact. Recent regulatory updates have emphasized the need for greener synthetic approaches, such as catalytic halogenation and solvent-free reactions, to reduce the ecological footprint associated with its production and use.

In conclusion, 2-Bromo-4-iodophenol (CAS: 133430-98-5) continues to be a valuable tool in chemical biology and pharmaceutical research. Its diverse applications, ranging from drug discovery to materials science, highlight its versatility and importance in modern scientific endeavors. Ongoing research efforts are expected to further expand its utility, particularly in the development of targeted therapies and sustainable materials. As the field advances, it will be crucial to balance innovation with safety and environmental stewardship to fully realize the potential of this remarkable compound.

• 216306-47-7(1,4-Benzenediol, 2-bromo-5-iodo-)
• 180639-95-6(Phenol, 2-bromo-6-iodo-4-methyl-)
• 15459-51-5(4-Bromo-2,6-diiodophenol)
• 755027-18-0(1-bromo-4-iodo-2-methoxybenzene)
• 2040-86-0(2-Bromo-6-iodophenol)
• 182056-39-9(2-Bromo-4-iodoanisole)
• 570391-20-7(3-Bromo-5-iodophenol)
• 207115-22-8(4-Bromo-2-iodophenol)
• 932372-99-1(2-Bromo-5-iodophenol)
• 863870-88-6(2-Bromo-3-iodophenol)